Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Improving reporting of multiple sclerosis relapse.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Transverse Myelitis.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
Assessment of the Effect of Cigarette Smoking on Regional Brain Volumes and Lesion Load in Patients with Clinically Isolated Syndrome.
Uhthoff phenomenon in osmotic demyelination syndrome.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea.
Visual issues in multiple sclerosis.
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Endogenous Two-Photon Excited Fluorescence Provides Label-Free Visualization of the Inflammatory Response in the Rodent Spinal Cord.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Neuropsychological rehabilitation for multiple sclerosis.
Pages
« first
‹ previous
…
493
494
495
496
497
498
499
500
501
…
next ›
last »